New radiation approach aims to spare healthy tissue in sinus cancer treatment
NCT ID NCT05943119
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 2 trial tests a new way to give radiation for sinus cancer after endoscopic surgery. Instead of radiating the whole sinus area, doctors will use a 'dose painting' technique that targets only the areas where cancer was found. The goal is to see if this reduces side effects like damage to the nose, eyes, ears, and brain. About 52 adults with sinus tumors will be randomly assigned to either the new targeted radiation or standard full-sinus radiation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Radiotherapy (dose-painting radiation)
What this could lead to
If successful, this approach could reduce severe side effects from radiation while still controlling sinus cancer.
What could go wrong
This is a small, early-phase trial (52 people). It may not show a clear benefit, and the targeted method might miss some cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR, SOLID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU CAEN
NOT_YET_RECRUITINGCaen, France
Contact
-
Centre Francois Baclesse
RECRUITINGCaen, France
Contact
-
Centre Oscar Lambret
NOT_YET_RECRUITINGLille, France
Contact